Literature DB >> 22914399

Periconceptional over-the-counter nonsteroidal anti-inflammatory drug exposure and risk for spontaneous abortion.

Digna R Velez Edwards1, Tiara Aldridge, Donna D Baird, Michele Jonsson Funk, David A Savitz, Katherine E Hartmann.   

Abstract

OBJECTIVE: To estimate the association between over-the-counter nonsteroidal anti-inflammatory drug (NSAID) exposure during the early first trimester and risk for spontaneous abortion (gestation before 20 weeks of gestation) in a prospective cohort.
METHODS: Women were enrolled in the Right from the Start study (2004-2010). Exposure data regarding over-the-counter NSAID use from the last menstrual period (LMP) through the sixth week of pregnancy were obtained from intake and first-trimester interviews. Pregnancy outcomes were self-reported and verified by medical records. Gestational age was determined from the LMP. Stage of development before loss was determined from study ultrasonography. Cox proportional hazards regression models were used to estimate the association between NSAID exposure and pregnancy outcome taking into account candidate confounders.
RESULTS: Among 2,780 pregnancies, 367 women (13%) experienced a spontaneous abortion. NSAID exposure was reported by 1,185 (43%) women. NSAID exposure was not associated with spontaneous abortion risk in unadjusted models (hazard ratio [HR] 1.01, 95% confidence interval [CI] 0.82-1.24) or models adjusted for maternal age (adjusted HR 1.00, 95% CI 0.81-1.23).
CONCLUSION: Our findings suggest that use of nonprescription over-the-counter NSAIDs in early pregnancy does not put women at increased risk of spontaneous abortion.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22914399      PMCID: PMC3427532          DOI: 10.1097/AOG.0b013e3182595671

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  23 in total

Review 1.  Implantation and the survival of early pregnancy.

Authors:  E R Norwitz; D J Schust; S J Fisher
Journal:  N Engl J Med       Date:  2001-11-08       Impact factor: 91.245

2.  Prescription and non-prescription analgesic use among the US adult population: results from the third National Health and Nutrition Examination Survey (NHANES III).

Authors:  Ryne Paulose-Ram; Rosemarie Hirsch; Charles Dillon; Katalin Losonczy; Michael Cooper; Yechiam Ostchega
Journal:  Pharmacoepidemiol Drug Saf       Date:  2003-06       Impact factor: 2.890

3.  Risk of adverse birth outcome and miscarriage in pregnant users of non-steroidal anti-inflammatory drugs: population based observational study and case-control study.

Authors:  G L Nielsen; H T Sørensen; H Larsen; L Pedersen
Journal:  BMJ       Date:  2001-02-03

4.  The ovulatory gonadotrophin surge stimulates cyclooxygenase expression and prostaglandin production by the monkey follicle.

Authors:  D M Duffy; R L Stouffer
Journal:  Mol Hum Reprod       Date:  2001-08       Impact factor: 4.025

5.  Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey.

Authors:  David W Kaufman; Judith P Kelly; Lynn Rosenberg; Theresa E Anderson; Allen A Mitchell
Journal:  JAMA       Date:  2002-01-16       Impact factor: 56.272

Review 6.  Implantation in the baboon: endometrial responses.

Authors:  A T Fazleabas; J J Kim; S Srinivasan; K M Donnelly; A Brudney; R C Jaffe
Journal:  Semin Reprod Endocrinol       Date:  1999

7.  Induction of delayed follicular rupture in the human by the selective COX-2 inhibitor rofecoxib: a randomized double-blind study.

Authors:  M Pall; B E Fridén; M Brännström
Journal:  Hum Reprod       Date:  2001-07       Impact factor: 6.918

8.  Exposure to non-steroidal anti-inflammatory drugs during pregnancy and risk of miscarriage: population based cohort study.

Authors:  De-Kun Li; Liyan Liu; Roxana Odouli
Journal:  BMJ       Date:  2003-08-16

9.  Anti-implantation effects of indomethacin and celecoxib in rats.

Authors:  Nongluck Sookvanichsilp; Pawitra Pulbutr
Journal:  Contraception       Date:  2002-05       Impact factor: 3.375

10.  Frequency of use of acetaminophen, nonsteroidal anti-inflammatory drugs, and aspirin in US women.

Authors:  Gary C Curhan; Andrea J Bullock; Susan E Hankinson; Walter C Willett; Frank E Speizer; Meir J Stampfer
Journal:  Pharmacoepidemiol Drug Saf       Date:  2002-12       Impact factor: 2.890

View more
  16 in total

Review 1.  Use of DMARDs and biologics during pregnancy and lactation in rheumatoid arthritis: what the rheumatologist needs to know.

Authors:  Megan L Krause; Shreyasee Amin; Ashima Makol
Journal:  Ther Adv Musculoskelet Dis       Date:  2014-10       Impact factor: 5.346

2.  Racial differences in risk of spontaneous abortions associated with periconceptional over-the-counter nonsteroidal anti-inflammatory drug exposure.

Authors:  Digna R Velez Edwards; Katherine E Hartmann
Journal:  Ann Epidemiol       Date:  2013-11-12       Impact factor: 3.797

Review 3.  Ongoing Pharmacological Management of Chronic Pain in Pregnancy.

Authors:  Bengt Källén; Margareta Reis
Journal:  Drugs       Date:  2016-06       Impact factor: 9.546

Review 4.  Pharmacological Approach to Managing Childhood-Onset Systemic Lupus Erythematosus During Conception, Pregnancy and Breastfeeding.

Authors:  Nicole Bitencourt; Bonnie L Bermas
Journal:  Paediatr Drugs       Date:  2018-12       Impact factor: 3.022

5.  Appreciation for analysis of how levonorgestrel works and reservations with the use of meloxicam as emergency contraception.

Authors:  A Patrick Schneider; Christopher Kubat; Christine M Zainer
Journal:  Linacre Q       Date:  2016-02

Review 6.  Pharmacological treatment of migraine during pregnancy and breastfeeding.

Authors:  Siri Amundsen; Hedvig Nordeng; Kateřina Nezvalová-Henriksen; Lars Jacob Stovner; Olav Spigset
Journal:  Nat Rev Neurol       Date:  2015-04       Impact factor: 42.937

7.  Maternal non-steroidal anti-inflammatory drug exposure during pregnancy and risk of miscarriage: a systematic review and meta-analysis.

Authors:  Xian-Hua Ying; Dan-Ni Bao; Hai-Yin Jiang; Yu-Dan Shi
Journal:  Eur J Clin Pharmacol       Date:  2021-10-11       Impact factor: 2.953

Review 8.  Migraine Treatment in Pregnancy and Lactation.

Authors:  Anne H Calhoun
Journal:  Curr Pain Headache Rep       Date:  2017-10-04

Review 9.  The positive effect of pregnancy in rheumatoid arthritis and the use of medications for the management of rheumatoid arthritis during pregnancy.

Authors:  Uday Raj Sharma; Akhila Nediyedath Rathnakaran; B P Prudhvi Raj; Gayathry Padinjakkara; Akanksh Das; Surendra Vada; Manjunatha P Mudagal
Journal:  Inflammopharmacology       Date:  2021-04-12       Impact factor: 4.473

Review 10.  Rheumatologic Medication Use During Pregnancy.

Authors:  Emily A Peterson; Jessica Lynton; Allison Bernard; Mark K Santillan; Brittany Bettendorf
Journal:  Obstet Gynecol       Date:  2020-05       Impact factor: 7.661

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.